13710 Struthers Rd. Suite 105B
Colorado Springs, CO 80921
1257 Lake Plaza Dr. Suite 105
Colorado Springs, CO 80906
13710 Struthers Rd. Suite 105B
Colorado Springs, CO 80921
1257 Lake Plaza Dr. Suite 105
Colorado Springs, CO 80906
GLP-1 medications like Semaglutide and Tirzepatide address two of the central challenges in type 2 diabetes: excess weight and impaired insulin response. In clinical studies, patients lost 15–20% of body weight on average while also seeing improvements in blood sugar markers. Colorado Slim’s physician-supervised program combines GLP-1 therapy with blood glucose monitoring and nutrition planning to support both outcomes. Results vary by individual. A physician evaluation determines whether GLP-1 therapy is appropriate for your situation.
If you have type 2 diabetes or prediabetes and have been told to lose weight, you already know the catch. The metabolic conditions that make weight loss harder — insulin resistance, elevated blood sugar, disrupted hunger signaling — are exactly what weight gain makes worse. It’s a cycle most diets don’t address.
That’s the problem GLP-1 therapy is built for. At Colorado Slim in Colorado Springs, physician-supervised GLP-1 treatment targets both sides of that equation: meaningful weight loss and improved blood sugar regulation, monitored together under one program.
Insulin resistance — the hallmark of type 2 diabetes — doesn’t just affect blood sugar. It directly disrupts how your body processes and stores fat. When cells don’t respond efficiently to insulin, the pancreas compensates by producing more. Higher insulin levels promote fat storage, particularly around the abdomen, and suppress the body’s ability to burn stored fat for energy.
Weight gain then worsens insulin resistance further. The cycle is self-reinforcing, and it’s why standard calorie restriction often produces limited results for patients with T2D or prediabetes. The underlying metabolic disruption keeps working against you.
GLP-1 medications interrupt this cycle directly. They stimulate insulin release when blood sugar is elevated, suppress glucagon (which raises blood sugar), and significantly reduce appetite by acting on hunger receptors in the brain. The result: weight comes down, and the metabolic environment that was sustaining insulin resistance starts to improve alongside it.
Semaglutide and Tirzepatide both belong to the GLP-1 receptor agonist class. Tirzepatide also activates GIP receptors, which may offer additional advantages for patients with significant insulin resistance — though a physician evaluation determines which medication is appropriate for your specific history.
For patients with T2D or prediabetes, the dual effect on weight and glucose is well-documented. Clinical trials on Tirzepatide showed average weight loss of 15–21% of body weight depending on dose, with meaningful reductions in HbA1c — the long-term blood sugar marker your physician tracks. Semaglutide trials showed similar weight outcomes alongside consistent improvements in fasting glucose and HbA1c.
These aren’t separate benefits. The weight loss itself improves insulin sensitivity, which improves blood sugar control, which makes further weight loss easier. Physician supervision ensures both are tracked and that your GLP-1 dosing is adjusted based on how your body is actually responding.
Colorado Slim’s program includes blood glucose monitoring as an active component — not just a baseline lab. Your glucose data informs how the physician adjusts your GLP-1 dose throughout treatment, and your nutrition plan is built around your individual glucose response patterns.
Colorado Slim’s initial evaluation determines candidacy. Generally, GLP-1 therapy is appropriate for patients who meet one or more of the following criteria:
GLP-1 therapy is not appropriate for every patient. Contraindications include a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Your physician will review your full history before any prescription is written.
Not sure whether GLP-1 therapy is right for your situation? Colorado Slim’s initial evaluation includes full labs, body composition analysis, and a physician review of your metabolic history — so you leave with a clear answer, not a sales pitch. Both Colorado Springs locations are accepting new patients. Call 719-741-7546 or book a consultation at coloradoslimpwl.com.
This is where physician supervision matters most for patients with T2D. GLP-1 medications lower blood sugar — which is the intended effect. But if you’re already on medications that lower blood sugar, coordination is essential to avoid hypoglycemia.
Colorado Slim’s physicians review your current medication list at intake. Dosing decisions and titration schedules account for any existing diabetes medications, and glucose monitoring throughout treatment allows for real-time adjustments. You are not managing this blind.
Metformin combined with GLP-1 therapy is generally well-tolerated and widely used together. Patients on insulin or sulfonylureas — medication classes that carry a higher hypoglycemia risk — require closer monitoring, particularly during the early weeks of GLP-1 titration. Your physician will outline the specific monitoring protocol for your medication combination at your first visit.
GLP-1 therapy is the foundation. The program around it is what separates physician-supervised treatment from a telehealth prescription.
Every patient starts with a comprehensive evaluation: full blood panel, body composition analysis, resting metabolic rate testing, and baseline glucose assessment. Nutrition planning is built around your glucose response patterns — not a generic calorie target. Ongoing follow-up visits allow your physician to adjust dosing and assess progress on both weight and metabolic markers.
For patients interested in addressing body composition alongside weight loss, Colorado Slim also offers body contouring services. Learn more about GLP-1 medications and the full program available at both Colorado Springs locations.
There are no contracts and no membership fees. Costs are discussed clearly at your initial consultation, and CareCredit financing is available.
In many cases, yes — but physician review is required. GLP-1 medications work differently than most diabetes medications and are often used alongside metformin without issue. However, if you’re on insulin or a sulfonylurea, your physician will build a monitoring protocol to manage hypoglycemia risk during titration. Never adjust your current medications without physician guidance
Colorado Slim tracks blood glucose throughout your program — not just at the initial evaluation. Your glucose data informs dose adjustments and helps your physician identify any response patterns that require attention. If you’re on medications that increase hypoglycemia risk, your monitoring frequency and titration pace will be adjusted accordingly.
Some patients do see improvements in blood sugar markers significant enough that their prescribing physician adjusts their diabetes medication. That is a decision made by your physician based on your lab results — it is not a guaranteed outcome and should not be anticipated without medical review. Colorado Slim shares relevant data with your PCP or endocrinologist on request.
No. Patients with prediabetes and a BMI of 27 or higher with metabolic risk factors are also candidates. The initial evaluation assesses your full metabolic picture — including fasting glucose, HbA1c, and insulin markers — to determine whether GLP-1 therapy is appropriate for your situation.
Yes. Colorado Slim provides a focused weight loss program that complements, rather than replaces, your existing care. Relevant lab results and treatment summaries can be shared with your PCP or endocrinologist. Many patients find their primary care physician is supportive of a dedicated program because it addresses what a standard office visit rarely has time to manage
Weight loss for type 2 diabetes in Colorado Springs doesn’t have to mean another round of generic advice. Colorado Slim’s physician-supervised program starts with your labs, your history, and your goals — then builds a GLP-1 treatment plan around all three.
Both Colorado Springs locations are accepting new patients. No contracts, no guesswork.
Call 719-741-7546 or book your consultation at coloradoslimpwl.com.
North: 13710 Struthers Rd, Suite 105B • South: 1257 Lake Plaza Dr, Suite 105
Results vary by individual. A physician evaluation determines whether GLP-1 therapy is appropriate for you.
